Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease - PubMed (original) (raw)
Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease
M P Conte et al. Gut. 2006 Dec.
Abstract
Background: Clinical and experimental observations in animal models indicate that intestinal commensal bacteria are involved in the initiation and amplification of inflammatory bowel disease (IBD). No paediatric reports are available on intestinal endogenous microflora in IBD.
Aims: To investigate and characterise the predominant composition of the mucosa-associated intestinal microflora in colonoscopic biopsy specimens of paediatric patients with newly diagnosed IBD.
Methods: Mucosa-associated bacteria were quantified and isolated from biopsy specimens of the ileum, caecum and rectum obtained at colonoscopy in 12 patients with Crohn's disease, 7 with ulcerative colitis, 6 with indeterminate colitis, 10 with lymphonodular hyperplasia of the distal ileum and in 7 controls. Isolation and characterisation were carried out by conventional culture techniques for aerobic and facultative-anaerobic microorganisms, and molecular analysis (16S rRNA-based amplification and real-time polymerase chain reaction assays) for the detection of anaerobic bacterial groups or species.
Results: A higher number of mucosa-associated aerobic and facultative-anaerobic bacteria were found in biopsy specimens of children with IBD than in controls. An overall decrease in some bacterial species or groups belonging to the normal anaerobic intestinal flora was suggested by molecular approaches; in particular, occurrence of Bacteroides vulgatus was low in Crohn's disease, ulcerative colitis and indeterminate colitis specimens.
Conclusion: This is the first paediatric report investigating the intestinal mucosa-associated microflora in patients of the IBD spectrum. These results, although limited by the sample size, allow a better understanding of changes in mucosa-associated bacterial flora in these patients, showing either a predominance of some potentially harmful bacterial groups or a decrease in beneficial bacterial species. These data underline the central role of mucosa-adherent bacteria in IBD.
Conflict of interest statement
Competing interests: None.
Figures
Similar articles
- Longitudinal Analyses of Gut-Associated Bacterial Microbiota in Ulcerative Colitis Patients.
Al-Bayati L, Nayeri Fasaei B, Merat S, Bahonar A. Al-Bayati L, et al. Arch Iran Med. 2018 Dec 1;21(12):578-584. Arch Iran Med. 2018. PMID: 30634855 - Detection of Listeria monocytogenes by polymerase chain reaction in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls.
Chen W, Li D, Paulus B, Wilson I, Chadwick VS. Chen W, et al. J Gastroenterol Hepatol. 2000 Oct;15(10):1145-50. doi: 10.1046/j.1440-1746.2000.02331.x. J Gastroenterol Hepatol. 2000. PMID: 11106094 - Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease.
Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Fölsch UR, Timmis KN, Schreiber S. Ott SJ, et al. Gut. 2004 May;53(5):685-93. doi: 10.1136/gut.2003.025403. Gut. 2004. PMID: 15082587 Free PMC article. - The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.
Linskens RK, Huijsdens XW, Savelkoul PH, Vandenbroucke-Grauls CM, Meuwissen SG. Linskens RK, et al. Scand J Gastroenterol Suppl. 2001;(234):29-40. doi: 10.1080/003655201753265082. Scand J Gastroenterol Suppl. 2001. PMID: 11768558 Review. - Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases.
Schultz M, Schölmerich J, Rath HC. Schultz M, et al. Dig Dis. 2003;21(2):105-28. doi: 10.1159/000073243. Dig Dis. 2003. PMID: 14571109 Review.
Cited by
- Probiotics in the Treatment of Inflammatory Bowel Diseases.
Guandalini S. Guandalini S. Adv Exp Med Biol. 2024;1449:135-142. doi: 10.1007/978-3-031-58572-2_8. Adv Exp Med Biol. 2024. PMID: 39060735 Review. - Juvenile ferric iron prevents microbiota dysbiosis and colitis in adult rodents.
Ettreiki C, Gadonna-Widehem P, Mangin I, Coëffier M, Delayre-Orthez C, Anton PM. Ettreiki C, et al. World J Gastroenterol. 2012 Jun 7;18(21):2619-29. doi: 10.3748/wjg.v18.i21.2619. World J Gastroenterol. 2012. PMID: 22690070 Free PMC article. - 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis.
Wang Y, Hoenig JD, Malin KJ, Qamar S, Petrof EO, Sun J, Antonopoulos DA, Chang EB, Claud EC. Wang Y, et al. ISME J. 2009 Aug;3(8):944-54. doi: 10.1038/ismej.2009.37. Epub 2009 Apr 16. ISME J. 2009. PMID: 19369970 Free PMC article. - Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.
Damaskos D, Kolios G. Damaskos D, et al. Br J Clin Pharmacol. 2008 Apr;65(4):453-67. doi: 10.1111/j.1365-2125.2008.03096.x. Epub 2008 Feb 12. Br J Clin Pharmacol. 2008. PMID: 18279467 Free PMC article. Review. - Infectious etiopathogenesis of Crohn's disease.
Carrière J, Darfeuille-Michaud A, Nguyen HT. Carrière J, et al. World J Gastroenterol. 2014 Sep 14;20(34):12102-17. doi: 10.3748/wjg.v20.i34.12102. World J Gastroenterol. 2014. PMID: 25232246 Free PMC article. Review.
References
- Dunne C. Adaptation of bacteria to the intestinal niche: probiotics and gut disorders. Inflamm Bowel Dis 20017136–145. - PubMed
- Hooper L V, Gordon J I. Commensal host‐bacterial relationships in the gut. Science 20012921115–1118. - PubMed
- Shanahan F. The host‐microbe interface within the gut. Best Pract Res Clin Gastroenterol 200216915–931. - PubMed
- Guarner F, Malagelada J R. Gut flora in health and disease. Lancet 2003361512–519. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources